Back

SGLT2 inhibitors in HFpEF - Light at the end of the tunnel.

29 August 2022 (12:45 - 13:00)
Organised by:
Congress Presentation Part of: SGLT-2 inhibitors - Another piece of the puzzle in heart failure Heart Failure with Preserved Ejection Fraction (HFpEF) Open Access ESC Congress 2022

About the speaker

Photo
Professor Scott Solomon

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

5 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors across the spectrum of heart failure.
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
Practical considerations for treating HF with mildly reduced and preserved EF.
Professor C. Lam (Singapore, SG)
Slides Video
Presentation thumbnail
Implementing best practices across the spectrum of heart failure.
Doctor M. Vaduganathan (Boston, US)
Slides Video
Presentation thumbnail
Summary.
Slides Video
Presentation thumbnail
Discussion.
Video

Access the full session

Session thumbnail
SGLT-2 inhibitors - Another piece of the puzzle in heart failure
Video

The Event

Event poster

ESC Congress 2022

29 August 2022 12:45 CET
You may be interested in
thumbnail
Congress Session
HOT LINE SESSION 4
27 August 2022
thumbnail
Congress Session
SGLT2 inhibitors in practice (part 2): how do we implement new treatments in HFpEF?
27 August 2022
thumbnail
Congress Presentation
Similarities and differences between SGLT2i trials in HFpEF
24 May 2022
thumbnail
Congress Session
State-of-the art treatment of HFmrEF and HFpEF in 2023
27 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources